CEO since 2021
Education: PhD in Applied Biochemistry and Physics from Linköping University. Master of Science in Biotechnology from Linköping University, including a master’s thesis project at Stanford University.
Previous experience: Peter has 20 years of experience in the pharmaceutical and biotechnology industries, including senior positions at BioChromix Pharma AB, Cadila Pharmaceuticals Sweden AB, Aegate Ltd and Olink Bioscience AB.
Holdings: 37,636 shares
CFO since 2026
Education: Master of Science in Business and Economics from the School of Business, Economics and Law at the University of Gothenburg.
Previous experience: Karin has more than 20 years of experience in senior roles within financial management and financing at global pharmaceutical companies. She joined Guard Therapeutics as CFO in September 2020.
Holdings: 5,121 shares
R&D Director and Project Management (consultant)
Education: Master of Science in Chemical Engineering, specializing in pharmaceuticals, from Uppsala University. Bachelor’s degree in Behavioural Science from Stockholm University.
Previous experience: Sofia has 20 years of experience in various project management roles within the life sciences industry, working in both SME companies and global pharmaceutical organizations. She has extensive expertise in leadership, external coordination, CMC, product transfers, GMP, manufacturing and lifecycle management. Her previous roles include senior positions at Xbrane Biopharma AB, Fresenius Kabi AB, Mercodia AB and Orexo AB.
Holdings: 26,868 shares
Commercial Director (consultant)
Education: Master of Science (M.Sc.) in Chemical and Administrative Sciences.
Previous experience: Martina has more than 25 years of commercial experience in the life sciences industry, with a background in sales, marketing and business development. Her previous roles include positions at Biacore, Affibody, and the contract development and manufacturing organizations Recipharm and NorthX Biologics.
Holdings: -